Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Medical Announces New ECLIA Analyzer

publication date: Apr 29, 2010
China Medical Technologies (中国医疗技术公司) has received approval from the SFDA for its AUTOMAGLIA 90 fully-automated ECLIA analyzer. The machine is a fully-automated analyzer for immunoassay analysis in various types of diseases and disorders. China Medical is targeting its existing FISH customers, including 400 large hospitals in China purchase significant numbers of FISH tests, for the new ECLIA machines. More details...

Stock Symbol: (NSDQ: CMED)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital